Influence of arginine deimination on antigenicity of fibrinogen

被引:19
作者
Hida, S [1 ]
Miura, NN [1 ]
Adachi, Y [1 ]
Ohno, N [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbiol Prod, Hachioji, Tokyo 1920392, Japan
关键词
antigenicity; autoantibodies; deiminated fibrinogen; peptidyl arginine deiminase; rheumatoid arthritis;
D O I
10.1016/j.jaut.2004.06.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoreactivity is controlled at various steps by numerous mechanisms and is a key to understanding and treating autoimmune disease. Recently, an antibody against deiminated fibrinogen (DI-FBG) was detected in patients with rheumatoid arthritis (RA) with high specificity and sensitivity. DI-FBG converted enzymically by peptidyl arginine deiminase, was also detected in synovial membrane. In the present study, we investigated whether antibody to DI-FBG is produced in mice immunized with DI-FBG. Mice were immunized with DI-FBG in the presence or absence of adjuvant. Production of the specific antibody was only induced with adjuvant. The resulting antibody was specific for DI-FBG and did not react with intact/native fibrinogen. Furthermore, it recognized deiminated human fibrinogen and cyclic citrullinated peptide (CCP). These results suggested that mouse fibrinogen acquires antigenicity in mice through deimination and therefore, autoantibody such as that detected in RA patients specifically may be induced. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 28 条
[1]   METHOTREXATE IN RHEUMATOID-ARTHRITIS - AN UPDATE [J].
BANNWARTH, B ;
LABAT, L ;
MORIDE, Y ;
SCHAEVERBEKE, T .
DRUGS, 1994, 47 (01) :25-50
[2]   Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors [J].
Bas, S ;
Perneger, TV ;
Seitz, M ;
Tiercy, JM ;
Roux-Lombard, P ;
Guerne, PA .
RHEUMATOLOGY, 2002, 41 (07) :809-814
[3]  
BOOKBINDER SA, 1984, CLIN EXP RHEUMATOL, V2, P185
[4]  
Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO
[5]  
2-2
[6]   Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis. [J].
Choy, EHS ;
Panayi, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :907-916
[7]  
Daoud Katja F., 1999, Comprehensive Therapy, V25, P427, DOI 10.1007/BF02944294
[8]  
ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362
[9]  
Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585
[10]   Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset [J].
Goldbach-Mansky, R ;
Lee, J ;
McCoy, A ;
Hoxworth, J ;
Yarboro, C ;
Smolen, JS ;
Steiner, G ;
Rosen, A ;
Zhang, C ;
Ménard, HA ;
Zhou, ZJ ;
Palosuo, T ;
Van Venrooij, WJ ;
Wilder, RL ;
Klippel, JH ;
Schumacher, HR ;
El-Gabalawy, HS .
ARTHRITIS RESEARCH, 2000, 2 (03) :236-243